The GCVRZ chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the GCVRZ chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The GCVRZ stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View GCVRZ Detailed Price Forecast - CNN Money||View GCVRZ Detailed Summary - Google Finance|
|View GCVRZ Detailed Summary - Yahoo! Finance||View GCVRZ Stock Research & Analysis - Zacks.com|
|View GCVRZ Trends & Analysis - Trade-Ideas||View GCVRZ Major Holders - Barrons|
|View GCVRZ Call Transcripts - NASDAQ||View GCVRZ Breaking News & Analysis - Seeking Alpha|
|View GCVRZ Annual Report - CompanySpotlight.com||View GCVRZ OTC Short Report - OTCShortReport.com|
|View GCVRZ Fundamentals - TradeKing||View GCVRZ SEC Filings - Bar Chart|
|View Historical Prices for GCVRZ - The WSJ||View Performance/Total Return for GCVRZ - Morningstar|
|View the Analyst Estimates for GCVRZ - MarketWatch||View the Earnings History for GCVRZ - CNBC|
|View the GCVRZ Earnings - StockMarketWatch||View GCVRZ Buy or Sell Recommendations - MacroAxis|
|View the GCVRZ Bullish Patterns - American Bulls||View GCVRZ Short Pain Metrics - ShortPainBot.com|
|View GCVRZ Stock Mentions - StockTwits||View GCVRZ Stock Mentions - PennyStockTweets|
|View GCVRZ Stock Mentions - Twitter||View GCVRZ Investment Forum News - Investor Hub|
|View GCVRZ Stock Mentions - Yahoo! Message Board||View GCVRZ Stock Mentions - Seeking Alpha|
|View Insider Transactions for GCVRZ - SECform4.com||View Insider Transactions for GCVRZ - Insider Cow|
|View GCVRZ Major Holdings Summary - CNBC||View Insider Disclosure for GCVRZ - OTC Markets|
|View Insider Transactions for GCVRZ - Yahoo! Finance||View Institutional Holdings for GCVRZ - NASDAQ|
|View GCVRZ Stock Insight & Charts - FinViz.com||View GCVRZ Investment Charts - StockCharts.com|
|View GCVRZ Stock Overview & Charts - BarChart||View GCVRZ User Generated Charts - Trading View|
How Regeneron Stock Performed in the First Half of October
Posted on Friday October 19, 2018
On October 15, Regeneron (REGN) closed at $377.55, which was 1.72% lower than its previous closing price on October 12. On October 15, the company had a market capitalization of $40.08 billion. Regeneron and Sanofi (SNY) are awaiting the FDA’s decision regarding Dupixent in its asthma indication by the Prescription Drug User Fee Act (or PDUFA) date of October 20.
Novartis in Q3 2018: Analysts Expect Revenue Growth
Posted on Monday October 15, 2018
Analysts expect Novartis’s revenues to increase ~4.9% to $13.02 billion in the third quarter of 2018. There has been operating revenue growth for all three of its segments in the quarter. Analysts expect Novartis’s Innovative Medicines segment to report revenue growth in the third quarter of 2018 compared to the third quarter of 2017.
An Update on Bausch + Lomb/International in October
Posted on Monday October 15, 2018
Bausch + Lomb/International, a subsidiary of Bausch Health (BHC), generated net revenues of $1.21 billion in the second quarter, compared to $1.22 billion in the second quarter of 2017. This increase reflects ~4.0% YoY (year-over-year) organic growth.
Analysts’ Estimates and Ratings for Novartis in October
Posted on Thursday October 11, 2018
Novartis’s (NVS) revenue is mainly driven by the strong performance of its Innovative Medicines segment, while Sandoz and Alcon also contribute to the company’s overall growth.